Email Updates

You are here

CONRAD 120

Status
Completed
Phase
I
Objective

To evaluate 1% tenofovir vaginal ring.

Prevention Option(s)
Microbicides
Multipurpose Prevention Technologies
Arms and Assigned Interventions
Description
1% tenofovir vaginal ring
Mode of Delivery
Ring
Products
1% tenofovir gel
ARMs
Experimental
Trial Sponsors
CONRAD
June 2012
December 2012
Enrollment
36
Population
Women
Sites

Eastern Virginia Medical School

Norfolk, Virginia
United States of America